Weekly Recap | PHARMARON -4.91%, convertible bond plan weighsWeekly Review·2 days ago, 11:42 PM03759-4.96%
PHARMARON Plans RMB2.18B Zero-coupon Convertible Bonds at Nearly 17% PremiumAASTOCKS News·Aug 26 at 08:56 PM03759-4.96%300759-1.10%
Pharmaron Beijing to Raise US$330 Million via Premium-Priced Convertible BondsTip Ranks·Aug 26 at 06:11 PM03759-4.96%300759-1.10%
Pharmaron Beijing Co., Ltd. Class H (17Q1) was downgraded to a Hold Rating at UBSTip Ranks·Aug 25 at 07:25 PM03759-4.96%300759-1.10%
Pharmaron Beijing announces extraordinary general meeting, H share class meetingPUBT·Aug 25 at 07:59 AM03759-4.96%300759-1.10%
Pharmaron Beijing Co., Ltd. Class H (17Q1) Receives a Buy from CitiTip Ranks·Aug 24 at 05:36 AM03759-4.96%300759-1.10%
G Sachs Raises PHARMARON TP to HKD33.2 on Strong CDMO Order MomentumAASTOCKS News·Aug 24 at 02:31 AM03759-4.96%300759-1.10%
Daiwa Raises PHARMARON TP to HKD38.5, Lifts EPS Forecasts as Management Raises Full-year Revenue GuidanceAASTOCKS News·Aug 24 at 02:06 AM03759-4.96%300759-1.10%
BofAS Lifts PHARMARON TP to HKD38.4 on Growth Driven by CDMO UpcycleAASTOCKS News·Aug 24 at 02:01 AM03759-4.96%300759-1.10%
Pharmaron Beijing announces 2026 extraordinary general meeting, H share class meetingPUBT·Aug 21 at 04:01 AM03759-4.96%300759-1.10%
M Stanley Raises PHARMARON TP to HKD35.6, Rating OverweightAASTOCKS News·Aug 21 at 02:21 AM03759-4.96%
